HMOX1 and familial pancreatic carcinoma: HO-1 overexpression can confer tumor cell resistance to apoptosis [65], and inhibition of HO-1 expression may increase the responsiveness of tumor cells such as prostate cancer [66] and pancreatic cancer cells [67] to radiotherapy and chemotherapy.